Skip to content
OVistoaIntelligence index
AboutMethodologyPricingDocs
Sign inSign up
BREAKINGPerson found dead in car after it plows into health club in Portland, Oregon38 min ago
Top StoriesUnited StatesCanadaWorldPoliticsGeneralBusinessTechHealthAviationSportsArtificial IntelligencePublishers

MedPage Today

May 1, 2026

Study Examines if Prenatal Exposure to Sedatives Is Linked to Psych Disorders
MedPage Todayby Kristen Monaco·May 1, 2026

Study Examines if Prenatal Exposure to Sedatives Is Linked to Psych Disorders

Political lean
OVistoa

Article-level news analysis, transparent scoring, and API tools for readers, publishers, and teams that need source context.

DMCA and copyright review

Copyright owners can submit notices, counter-notices, and source material concerns through the dedicated review flow.

Open DMCA review

Product

  • Home
  • Feed
  • Search
  • Topics
  • Saved

Platform

  • About
  • Methodology
  • Home
  • Search
  • Saved
  • Me
center
Source quality85/100
Factual ratio90/100
Framing20/100

Prenatal exposure to benzodiazepines or Z-hypnotics was not associated with an increased risk of psychiatric or neurodevelopmental disorders in children in a South Korean cohort study.An initial link was observed, but it disappeared in a sibling-controlled analysis, suggesting that familial or environmental factors -- rather than medication -- was driving the association.While the findings offer reassurance, the researchers cautioned that this study does not rule out other pregnancy risks, such as miscarriages or congenital malformations. Prenatal exposure to sedative drugs used for anxiety and insomnia was not associated with an increased risk of psychiatric or neurodevelopmental conditions in children when accounting for familial factors, a large population-based cohort study from South Korea indicated. An analysis of 3.8 million children initially suggested that prenatal exposure to benzodiazepines or Z-hypnotics was tied to a higher risk of psychiatric disorders compared with no exposure over a median 6.85-year follow-up, but this association disappeared in a sibling-controlled analysis (HR 0.99, 95% CI 0.94-1.04). This suggested that familial or environmental factors -- rather than the medication itself -- likely drove the initial findings, noted Ju-Young Shin, PhD, of Sungkyunkwan University in Seoul, and colleagues. Furthermore, there were no increased risks for 12 individual disorders, the

Read at MedPage TodayCompare full coverage

Lean: 0.000 · Source quality 85/100 · Factual vs opinion 90/100.

Score signature

Political lean

Political leancenterSource quality85/100Factual ratio90/100Framing20/100

Methodology

v1
100
Source diversity
across 1 outlet
Compare full coverage
  • Pricing
  • API docs
  • Publishers
  • Account

    • Sign in
    • Create account
    • Reader settings
    • API console

    Legal

    • Terms
    • Privacy
    • Security
    • DMCA

    © 2026 Vistoa. All rights reserved.

    Limited excerpts, attribution, analysis, and outbound publisher links remain core product boundaries.